Implications of positive surgical margins

Area of Science:

• Oncology
• Head and Neck Cancer Treatment
• Clinical Trials

Background:

• Advanced squamous cell carcinoma of the head and neck often presents challenges in achieving negative surgical margins.
• The Head and Neck Intergroup trial investigated the efficacy of adding chemotherapy to standard treatment for operable head and neck cancers.

Purpose of the Study:

• To evaluate the impact of adding cisplatin-based chemotherapy to surgery and radiotherapy for patients with advanced operable squamous cell carcinoma of the head and neck.
• To analyze outcomes for patients with positive surgical margins who were excluded from the main trial.

Main Methods:

• The study followed 112 patients with positive surgical margins who received varied treatments post-surgery and radiotherapy.
• Data on clinical response and survival were collected and analyzed for this subgroup.

Main Results:

• Positive surgical margins were more frequent in nonglottic tumors and with higher N stage.
• Patients with positive margins achieving a complete clinical response had a median survival of 33.8 months, compared to 9.1 months for those with less than a complete response.
• The addition of chemotherapy did not significantly change the median survival for patients with positive margins.

Conclusions:

• Achieving a complete clinical response is a critical prognostic factor for patients with positive surgical margins in head and neck cancer.
• Chemotherapy did not demonstrate a significant survival benefit for this specific patient group (positive margins) within the trial's context.